Find a Tender
complete
Official procurement procedure
QUB/2598/24 - Contract for the Supply of a microfluidic system for single cell sorting and antibody discovery workflows and any ancillary or consumables products.
Medical equipments
Miscellaneous medical devices and products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Queens University Belfast: "QUB/2598/24 - Contract for the Supply of a microfluidic system for single cell sorting and antibody discovery workflows and any ancillary or consumables products.". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Queens University Belfast | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Queens University Belfast
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Queens University Belfast. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 3 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityQueens University Belfast | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published6 Dec 2024, 09:14 GMT | Last source update6 Dec 2024, 09:14 GMT | Recurring procurementNot published |
ClassificationMedical equipments, Miscellaneous medical devices and products | ||
Delivery area | ||
OCIDocds-h6vhtk-04a3fc | ||
What is being bought
Queen’s University of Belfast wishes to procure a single cell microfluidic encapsulation system to enhance productivity cell line development and antibody discovery workflows. We aim to detect expression levels of specific antibodies on a single cell level and isolate these cells for further expansion. To this end, we require an encapsulation system which can analyse secreted antibodies and sorting cells in a sterile environment. To accelerate cell line development workflows, we require a system which can ensure monoclonality and excellent cell viability following isolation.
What changed
From the official release history
- Status changed to complete
6 Dec 2024, 09:14 GMT - Official notice release published
6 Dec 2024, 09:14 GMT - Submission deadline changed to published date
6 Dec 2024, 09:14 GMT - Status changed to active
30 Sept 2024, 10:16 BST - Official notice release published
30 Sept 2024, 10:16 BST - Submission deadline changed to 29 Oct 2024, 16:00 GMT
30 Sept 2024, 10:16 BST - Buyer information updated
30 Sept 2024, 10:16 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedQueen’s University of Belfast wishes to procure a single cell microfluidic encapsulation system to enhance productivity cell line development and antibody discovery workflows. We aim to detect expression levels of specific antibodies on a single cell level and isolate these cells for further expansion. To this end, we require an encapsulation system which can analyse secreted antibodies and sorting cells in a sterile environment. To accelerate cell line development workflows, we require a system which can ensure monoclonality and excellent cell viability following isolation.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
6 Dec 2024, 09:14 GMT - Award active
Not published · Not published - Contract active
Signed 19 Nov 2024, 00:00 GMT · £750,000
Commercial outcome and competition
Awards Sphere Fluidics Not published · Not published · active |
Contracts Supply, Delivery, Installation, Commissioning and Maintenance of a microfluidic system for single cell sorting and antibody discovery workflows and any ancillary or consumables products. £750,000 · signed 19 Nov 2024, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) electronicBids: 1 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 1 (lot 1) smeBids: 1 (lot 1) |
Buyer and organisations in this procedure
Queens University Belfast
Contracting authority GB-FTS-3715Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published